Akoya Biosciences, Inc.
AKYA
$1.24
$0.119.74%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.45% | -18.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.45% | -18.78% | |||
| Cost of Revenue | -1.90% | -27.49% | |||
| Gross Profit | 22.73% | -12.42% | |||
| SG&A Expenses | 6.92% | -23.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.19% | -23.20% | |||
| Operating Income | 22.82% | 32.50% | |||
| Income Before Tax | 21.76% | 19.94% | |||
| Income Tax Expenses | -118.18% | -6.38% | |||
| Earnings from Continuing Operations | 22.16% | 19.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.16% | 19.90% | |||
| EBIT | 22.82% | 32.50% | |||
| EBITDA | 30.75% | 38.29% | |||
| EPS Basic | 22.27% | 20.03% | |||
| Normalized Basic EPS | -3.23% | 26.67% | |||
| EPS Diluted | 22.27% | 20.03% | |||
| Normalized Diluted EPS | -3.23% | 26.67% | |||
| Average Basic Shares Outstanding | 0.11% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
